MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable, net
$2,048K
Inventories, net
$1,909K
Cash and cash
equivalents
$1,072K
Prepaid expenses and
other current assets
$966K
Property and equipment,
gross
$469K
Investment in convertible
bond
$11,664K
Total current assets
$5,995K
Right of use assets
$736K
Other assets
$203K
Property and equipment,
net
$98K
Less accumulated
depreciation
$371K
Total assets
$18,696K
Accumulated deficit
-$273,402K
Net loan receivable
from ej holdings
$16,869K
Accumulated other
comprehensive loss
-$3,647K
Total liabilities and
stockholders' deficit
$18,696K
Total stockholders
deficit
-$67,860K
Additional paid-in capital
$225,988K
Common stock, par value
0.001 per share,...
$70K
Total liabilities
$86,556K
Total current
liabilities
$70,537K
Other long-term
liabilities
$12,418K
Notes payable to
related parties, net of...
$2,277K
Operating lease
liabilities, less current...
$1,324K
Accounts payable and
accrued expenses
$24,487K
Other current
liabilities
$17,443K
Convertible notes payable,
net of discount
$17,356K
Notes payable to
related...
$7,529K
Notes payable to
related...
$3,123K
Operating lease
liabilities, current portion
$349K
Conversion feature
derivative, notes payable
$235K
Warrant derivative
liabilities
$15K
Back
Back
Balance Sheet
Emmaus Life Sciences, Inc. (EMMA)
Emmaus Life Sciences, Inc. (EMMA)
source: myfinsight.com